Truist Securities initiates Viatris stock with Buy rating, sets $15 target

Investing.com - Truist Securities initiated coverage on Viatris (NASDAQ:VTRS) with a Buy rating and a $15.00 price target on Wednesday. According to InvestingPro analysis, the stock appears undervalued, with shares trading at just 0.74 times book value and showing a robust free cash flow yield of 15%.

The research firm cited the pharmaceutical company’s "affirmative change" under its refreshed leadership team as a key factor in the positive outlook.

Truist highlighted Viatris’s market-leading branded portfolio, progressive generics foothold, and robust pipeline with "blockbuster potential" as supporting factors for the rating.

The firm noted that additional upside potential could come from an earlier-than-anticipated return to full operations at the company’s Indore manufacturing facility.

Truist also mentioned that "overdelivery on its pipeline" could provide further growth opportunities, while acknowledging that "legacy Viatris concerns are still prevalent across the franchise."

In other recent news, Viatris Inc. reported its second-quarter earnings for 2025, exceeding analyst expectations with an earnings per share of $0.62, surpassing the forecasted $0.55. The company also outperformed revenue projections, reporting $3.57 billion compared to the anticipated $3.47 billion. Additionally, Viatris received approval from the U.S. Food and Drug Administration for its Iron Sucrose Injection, USP, marking the first generic version of Venofer Injection. This intravenous product is used to treat iron deficiency anemia in patients with chronic kidney disease and will be available in three different strengths.

In terms of leadership changes, Viatris has appointed Andrew Enrietti to the newly established position of Chief Administrative and Transformation Officer. Enrietti will oversee various functions including Human Relations, Business Transformation, and Information Technology. These developments reflect the company’s ongoing efforts to centralize leadership and streamline operations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.